Skip to content
Skip to content
Open navigation

Latest News

ANA Flame
Latest News

Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2

A symptom-based strategy for determining when HCP with SARS-CoV-2 infection could return to work is preferred in most clinical situations.

Read more

Interim Infection Prevention and Control Recommendations to Prevent SARS-CoV-2 Spread in Nursing Homes

Even as nursing homes resume normal practices, they must sustain core IPC practices and remain vigilant for SARS-CoV-2 infection among residents and HCP in order to prevent spread and protect residents and HCP from severe infections, hospitalizations, and death.

Read more

Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease (COVID-19) Pandemic

CDC has updated select healthcare infection prevention and control (IPC) recommendations in response to COVID-19 vaccination, which are now summarized in this guidance.

Read more

The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network

This report provides a national view of the increases in HAI incidence in 2020. These data highlight the need to return to conventional infection prevention and control practices and build resiliency in these programs to withstand future pandemics.

Read more

Notes from the Field: Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021

Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021

Read more

FDA Revokes Emergency Use Authorizations for Certain Respirators and Decontamination Systems

Throughout the pandemic, the FDA has worked closely with our federal partners at the Centers for Disease Control and Prevention’s National Institute for Occupational Safety and Health (NIOSH), the Occupational Safety and Health Administration (OSHA) and with manufacturers to protect our front-line workers by facilitating access to the medical supplies they require. As a result of these efforts, our country is now better positioned to provide health care workers with access to NIOSH-approved N95s rather than using non-NIOSH-approved respirators or reusing decontaminated disposable respirators.

Read more

Clean Indoor Air Is Vital for Infection Control

In the aftermath of the COVID-19 pandemic, scientists say it's time to rate indoor air quality and clean it to prevent the spread of airborne illnesses.

Read more

FDA Recommends Transition from Use of Decontaminated Disposable Respirators

The U.S. Food and Drug Administration (FDA) is recommending health care personnel and facilities transition away from crisis capacity conservation strategies, such as decontaminating or bioburden reducing disposable respirators for reuse. Based on the increased domestic supply of new respirators approved by the Centers for Disease Control and Prevention’s (CDC) National Institute for Occupational Safety and Health (NIOSH) currently available to facilitate this transition, the FDA and CDC believe there is adequate supply of respirators to transition away from use of decontamination and bioburden reduction systems.  

Read more

Infections Associated with Urological Endoscopes

The U.S. Food and Drug Administration (FDA) wants to raise awareness among health care providers, including those working in reprocessing units in health care facilities, about the risk of infections associated with reprocessed urological endoscopes, including cystoscopes, ureteroscopes, and cystourethroscopes, used for viewing and accessing the urinary tract. The FDA has received numerous Medical Device Reports (MDRs) which describe patient infections post procedure or other possible contamination issues associated with reprocessing these devices.

Read more



The Project Firstline program is a national training collaborative led by the Centers for Disease Control and Prevention (CDC) in partnership with ANA and the American Academy of Pediatrics, a 501(c)(3) nonprofit entity.

Want to learn more about Project Firstline? Contact

Project Firstline is a national collaborative led by the U.S. Centers for Disease Control and Prevention (CDC) to provide infection control training and education to frontline health care workers and public health personnel. ANA is proud to partner with Project Firstline, as supported through Cooperative Agreement CDC-RFA-OT18-1802. CDC is an agency within the Department of Health and Human Services (HHS). The contents of this webpage do not necessarily represent the policies of CDC or HHS and should not be considered an endorsement by the Federal Government.

As a key partner in this initiative, ANA is pleased to help bring critical training opportunities and resources to better equip all nurses with the tools necessary to provide optimal patient care in a safe environment. Placement of content on this website is not an endorsement of the source nor of any particular product or service, nor should it be construed as a statement that the source, or its products or services, are superior to those of any others. ANA and/or Project Firstline may not be the primary source of the content on this website. While we make every effort to provide up-to-date relevant content, resources or information may not have been updated yet to include recent changes, new findings, recommendations, or protocols.

You are now leaving the American Nurses Foundation

The American Nurses Foundation is a separate charitable organization under Section 501(c)(3) of the Internal Revenue Code. The Foundation does not engage in political campaign activities or communications.

The Foundation expressly disclaims any political views or communications published on or accessible from this website.

Continue Cancel

Item(s) added to cart

Go to cart Continue Shopping